Evidence map›Paper›PMID 42560300›Full record

ArticlePolish journal of microbiology2026

Xuelian He, Shang Ma, Yanyan Zhou, Jingjuan Wei, Zhongling Zhuo, Liyan Ma

Abstract read
In one paragraph

Article in Polish journal of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xuelian He1Beijing Friendship Hospital, Capital Medical University, Beijing China.
Shang Ma2Beijing Chest Hospital, Capital Medical University, Beijing China.
Yanyan Zhou1Beijing Friendship Hospital, Capital Medical University, Beijing China.
Jingjuan Wei1Beijing Friendship Hospital, Capital Medical University, Beijing China.
Zhongling Zhuo1Beijing Friendship Hospital, Capital Medical University, Beijing China.
Liyan Ma1Beijing Friendship Hospital, Capital Medical University, Beijing China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of carbapenem-resistant

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsAzabicyclo CompoundsCarbapenemsDrug Resistance, Multiple, BacterialSulbactamTetracyclinesAcinetobacter InfectionsChinaDrug Resistance, BacterialHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsAzabicyclo CompoundsCarbapenemsdurlobactameravacyclineSulbactamTetracyclinesAcinetobacter baumanniicarbapenem-resistanteravacyclinesulbactam-durlobactam

Identifiers

PMID42560300
PMCPMC13446369

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.